The Secretary of State for Health and Social Care's letter has been sent to a group of charities, including the National Kidney Federation and patients on the decision not to procure Evusheld as a COVID-19 treatment.

The letter gives an overview of the:

  • information that was used in the decision by the UK government not to procure Evusheld (tixagevimab plus cilgavimab) as a pre-exposure prophylaxis used in the treatment of COVID-19
  • expert advice provided by the research to access pathway for investigational drugs for COVID-19 (RAPID C-19) Oversight Group, and the limitations of the data available
  • next steps the government is considering

To view the letter please visit here

The National Kidney Federation support the Evusheld for the UK campaign, together advocating for the availability and we continue to ask the UK government to procure Evusheld urgently. To help with the campaign…

Write to your local MP and members of the House of lords

For more ways on how to take action visit: